Low T3 syndrome and long-term mortality in chronic hemodialysis patients
- PMID: 26167466
- PMCID: PMC4491933
- DOI: 10.5527/wjn.v4.i3.415
Low T3 syndrome and long-term mortality in chronic hemodialysis patients
Abstract
Aim: To investigate the predictive value of low freeT3 for long-term mortality in chronic hemodialysis (HD) patients and explore a possible causative role of chronic inflammation.
Methods: One hundred fourteen HD patients (84 males) consecutively entered the study and were assessed for thyroid function and two established markers of inflammation, high sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6). Monthly blood samples were obtained from all patients for three consecutive months during the observation period for evaluation of thyroid function and measurement of inflammatory markers. The patients were then divided in two groups based on the cut-off value of 1.8 pg/mL for mean plasma freeT3, and were prospectively studied for a mean of 50.3 ± 30.8 mo regarding cumulative survival. The prognostic power of low serum fT3 levels for mortality was assessed using the Kaplan-Meier method and univariate and multivariate regression analysis.
Results: Kaplan-Meier survival curve showed a negative predictive power for low freeT3. In Cox regression analysis low freeT3 remained a significant predictor of mortality after adjustment for age, diabetes mellitus, hypertension, hsCRP, serum creatinine and albumin. Regarding the possible association with inflammation, freeT3 was correlated with hsCRP, but not IL-6, and only at the first month of the study.
Conclusion: In chronic hemodialysis patients, low plasma freeT3 is a significant predictor of all-cause mortality. Further studies are required to identify the underlying mechanisms of this association.
Keywords: C-reactive protein; Hemodialysis; Inflammation; Interleukin-6; Low T3 syndrome; Mortality.
Figures
Similar articles
-
Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.Nephron Clin Pract. 2011;119(2):c162-70. doi: 10.1159/000327615. Epub 2011 Jul 8. Nephron Clin Pract. 2011. PMID: 21757955
-
Are low concentrations of serum triiodothyronine a good marker for long-term mortality in hemodialysis patients?Clin Nephrol. 2010 Mar;73(3):238-40. doi: 10.5414/cnp73238. Clin Nephrol. 2010. PMID: 20178724
-
Association of triiodothyronine levels with left ventricular function, cardiovascular events, and mortality in hemodialysis patients.Int J Artif Organs. 2017 Mar 16;40(2):60-66. doi: 10.5301/ijao.5000569. Epub 2017 Feb 28. Int J Artif Organs. 2017. PMID: 28315504
-
Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S28-36. J Am Soc Nephrol. 2002. PMID: 11792759
-
Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients.Braz J Med Biol Res. 2005 May;38(5):783-8. doi: 10.1590/s0100-879x2005000500017. Epub 2005 May 25. Braz J Med Biol Res. 2005. PMID: 15917961
Cited by
-
Early detection of thiamine deficiency by non-thyroidal illness syndrome in a hemodialysis patient.CEN Case Rep. 2023 Feb;12(1):110-115. doi: 10.1007/s13730-022-00729-8. Epub 2022 Aug 26. CEN Case Rep. 2023. PMID: 36018508 Free PMC article.
-
Nocturnal haemodialysis is associated with a reduced occurrence of low triiodothyronine serum levels in haemodialysed patients.Clin Kidney J. 2020 Feb 10;13(3):450-460. doi: 10.1093/ckj/sfaa003. eCollection 2020 Jun. Clin Kidney J. 2020. PMID: 32699626 Free PMC article.
-
Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14).Front Oncol. 2021 Nov 25;11:787835. doi: 10.3389/fonc.2021.787835. eCollection 2021. Front Oncol. 2021. PMID: 34900742 Free PMC article.
-
Thyroid dysfunction and kidney disease: An update.Rev Endocr Metab Disord. 2017 Mar;18(1):131-144. doi: 10.1007/s11154-016-9395-7. Rev Endocr Metab Disord. 2017. PMID: 27864708 Review.
-
Thyroid, Gonadal and Adrenal Dysfunction in Kidney Transplant Recipients: A Review for the Clinician.Biomolecules. 2023 May 31;13(6):920. doi: 10.3390/biom13060920. Biomolecules. 2023. PMID: 37371500 Free PMC article. Review.
References
-
- Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske BL, Kutner N, Liu J, et al. US Renal Data System 2013 Annual Data Report. Am J Kidney Dis. 2014;63:A7. - PubMed
-
- Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006;47:139–148. - PubMed
-
- Carrero JJ, Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol. 2009;4 Suppl 1:S49–S55. - PubMed
-
- Ortiz A, Massy ZA, Fliser D, Lindholm B, Wiecek A, Martínez-Castelao A, Covic A, Goldsmith D, Süleymanlar G, London GM, et al. Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis. Nat Rev Nephrol. 2012;8:141–150. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials